Haw Par Corporation Limited
Research Haw Par Corporation Limited (H02.SI) on Bullrun: market cap SGD 2.86B, P/E 12.4, dividend yield 3.1%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerH02.SI
- ExchangeSGX
- CountrySingapore
- SectorHealthcare
- IndustryDrug Manufacturers - General
- CurrencySGD
- Market capSGD 2.86B
- P/E12.4
- Dividend yield3.1%
- Financial periodFY2025
- RevenueSGD 229.97M
- Revenue growth-6.1%
- Net incomeSGD 265.46M
- Free cash flowSGD 55.01M
- Gross margin56.0%
Valuation Snapshot
latest market cap is SGD 2.86B; P/E is 12.4; dividend yield is 3.1%.
Peer valuation comparison
Latest P/E is 12.44x versus a Healthcare sector median of 21.69x (42.6% below).
Latest dividend yield is 3.09% versus a Healthcare sector median of 2.41% (28.2% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SGD 229.97M | SGD 265.46M | SGD 55.01M | 56.0% | 1.2 | SGD 791.43M | SGD 44.69M | SGD 4.29B |
| FY2024 | SGD 244.82M | SGD 228.27M | SGD 50.33M | 54.8% | 1.03 | SGD 745.78M | SGD 36.77M | SGD 4.15B |
| FY2023 | SGD 232.06M | SGD 216.57M | SGD 54.92M | 58.1% | 0.98 | SGD 574.01M | SGD 28.48M | SGD 3.48B |
| FY2022 | SGD 182.09M | SGD 148.32M | SGD 21.21M | 54.1% | 0.67 | SGD 334.27M | SGD 29.20M | SGD 3.55B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | SGD 2.86B | 12.4 | 3.1% | 0.4 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.4 SGD, yield 3.1%.
| Year | Dividends/share |
|---|---|
| FY2025 | 1.4 SGD |
| FY2024 | 0.4 SGD |
| FY2023 | 0.35 SGD |
| FY2022 | 0.3 SGD |
About Haw Par Corporation Limited
Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, The Association of Southeast Asian Nations countries, other Asian countries, and internationally. It manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands; and invests in quoted securities. The company also owns and leases various investment properties.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Haw Par Corporation Limited's market cap?
Haw Par Corporation Limited's market capitalization is SGD 2.86B.
What is Haw Par Corporation Limited's P/E ratio?
Haw Par Corporation Limited's price-to-earnings (P/E) ratio is 12.4.
Does Haw Par Corporation Limited pay a dividend?
Haw Par Corporation Limited has a dividend yield of 3.1%.
What does Haw Par Corporation Limited do?
Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, The Association of Southeast Asian Nations countries, other Asian countries, and internationally. It manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands; and invests in quoted securities. The company also owns and leases various investment properties. In addition, it provides family and tourist oriented leisure activities primarily in the form of oceanariums.